Bio-Rad Labs (BIO) Tops Q1 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bio-Rad Labs (BIO) PT Lifted to $165 at Jefferies
May 6, 2015 8:09 AM EDTJefferies analyst Brandon Couillard reiterated a Buy rating and lifted his price target on Bio-Rad Labs (NYSE: BIO) to $165.00 (from $150.00) following much better-than-expected Q1 results.
Couillard commented, "BIO's 1Q15 EPS of $0.61 dusted our view ($0.36) on vastly better profitability, despite a sizable... More
